Kaveri Pohlman
Stock Analyst at BTIG
(0.50)
# 3,881
Out of 4,735 analysts
21
Total ratings
25%
Success rate
-24.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kaveri Pohlman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGNX MacroGenics | Downgrades: Neutral | n/a | $3.00 | - | 4 | Aug 1, 2024 | |
| GMAB Genmab | Maintains: Buy | $46 → $47 | $21.80 | +115.60% | 3 | Jun 27, 2024 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $20 → $30 | $10.42 | +187.91% | 2 | Apr 17, 2024 | |
| XNCR Xencor | Maintains: Buy | $56 → $38 | $20.45 | +85.82% | 1 | Apr 16, 2024 | |
| NUVB Nuvation Bio | Upgrades: Buy | $5 | $2.58 | +93.80% | 2 | Mar 26, 2024 | |
| JANX Janux Therapeutics | Initiates: Buy | $62 | $40.91 | +51.55% | 1 | Mar 21, 2024 | |
| PYXS Pyxis Oncology | Initiates: Buy | $8 | $1.53 | +422.88% | 1 | Feb 9, 2024 | |
| EXEL Exelixis | Initiates: Buy | $27 | $36.43 | -25.89% | 1 | Dec 19, 2023 | |
| RCUS Arcus Biosciences | Reiterates: Buy | $70 | $14.14 | +395.05% | 1 | Aug 23, 2023 | |
| STTK Shattuck Labs | Initiates: Buy | $12 | $1.15 | +943.48% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $8 | $0.87 | +818.27% | 2 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12,320 → $4,928 | $1.54 | +319,900.00% | 2 | Feb 9, 2022 |
MacroGenics
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.00
Upside: -
Genmab
Jun 27, 2024
Maintains: Buy
Price Target: $46 → $47
Current: $21.80
Upside: +115.60%
Cullinan Therapeutics
Apr 17, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $10.42
Upside: +187.91%
Xencor
Apr 16, 2024
Maintains: Buy
Price Target: $56 → $38
Current: $20.45
Upside: +85.82%
Nuvation Bio
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $2.58
Upside: +93.80%
Janux Therapeutics
Mar 21, 2024
Initiates: Buy
Price Target: $62
Current: $40.91
Upside: +51.55%
Pyxis Oncology
Feb 9, 2024
Initiates: Buy
Price Target: $8
Current: $1.53
Upside: +422.88%
Exelixis
Dec 19, 2023
Initiates: Buy
Price Target: $27
Current: $36.43
Upside: -25.89%
Arcus Biosciences
Aug 23, 2023
Reiterates: Buy
Price Target: $70
Current: $14.14
Upside: +395.05%
Shattuck Labs
Aug 31, 2022
Initiates: Buy
Price Target: $12
Current: $1.15
Upside: +943.48%
Jul 7, 2022
Maintains: Buy
Price Target: $16 → $8
Current: $0.87
Upside: +818.27%
Feb 9, 2022
Maintains: Buy
Price Target: $12,320 → $4,928
Current: $1.54
Upside: +319,900.00%